How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Toilet for Obese Patients Market
- By Product Type: Standard Bariatric Toilets, Commode Chairs for Obese Patients, Raised Height Toilets, Portable Bariatric Toilets, Electric Bidet Toilets for Obese Users
- By Material: Stainless Steel, High-Density Polyethylene (HDPE), Reinforced Plastic, Powder-Coated Steel, Composite Materials
- By Installation Type: Floor-Mounted Bariatric Toilets, Wall-Mounted Bariatric Toilets, Portable/Commode Toilets, Integrated Bidet Toilets
- By Weight Capacity: Up to 400 lbs, 400-600 lbs, 600-800 lbs, Above 800 lbs
- By End User: Hospitals and Healthcare Facilities, Nursing Homes and Assisted Living, Home Care Settings, Rehabilitation Centers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Standard Bariatric Toilets leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Toilet for Obese Patients Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Material 5
Installation Type 4
Weight Capacity 4
End User 4
Companies profiled
Drive DeVilbiss Healthcare
Medline Industries
Invacare Corporation
Arjo
Hill-Rom Holdings (now part of Baxter International)
Etac AB
Carex Health Brands
Nova Medical Products
Graham-Field Health Products
MJM International
Ableware by Maddak
NOVA Medical Products
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Drive DeVilbiss Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medline Industries
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Invacare Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Arjo
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Hill-Rom Holdings (now part of Baxter International)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Etac AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Carex Health Brands
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nova Medical Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Graham-Field Health Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →MJM International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Ableware by Maddak
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →NOVA Medical Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Karman Healthcare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Essential Medical Supply
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Medline Mobility
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,236M by 2033 · 10.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Standard Bariatric Toilets37.3
- Commode Chairs for Obese Patients20.9
- Raised Height Toilets20.5
- Portable Bariatric Toilets10.9
- Electric Bidet Toilets for Obese Users10.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,555M → $3,664M · 11.3%
Europe$1,084M → $2,390M · 10.4%
Asia Pacific$989.8M → $2,336M · 11.3%
Latin America$612.8M → $1,316M · 10.0%
Middle East and Africa$471.4M → $981.1M · 9.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.132026
10.142027
10.162028
10.172029
10.172030
10.192031
10.212032
10.222033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Drive DeVilbiss Healthcare21.7
- Medline Industries15.8
- Invacare Corporation8.1
- Arjo7.7
- Hill-Rom Holdings (now part of Baxter International)9.1
- Etac AB9.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type26.8%
Material14.7%
Installation Type10.1%
Weight Capacity33.2%
End User15.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.3
- Europe22.4
- Asia Pacific21.9
- Latin America12.3
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Drive DeVilbiss Healthcare | 95 | 95 | 90 | 90 | 78 | 78 | 88 |
| Medline Industries | 86 | 85 | 91 | 86 | 91 | 76 | 86 |
| Invacare Corporation | 72 | 84 | 84 | 75 | 85 | 64 | 77 |
| Arjo | 67 | 71 | 59 | 76 | 76 | 80 | 72 |
| Hill-Rom Holdings (now part of Baxter International) | 68 | 72 | 72 | 53 | 74 | 74 | 69 |
| Etac AB | 69 | 69 | 66 | 66 | 50 | 49 | 62 |
| Carex Health Brands | 44 | 44 | 44 | 44 | 62 | 48 | 48 |
| Nova Medical Products | 57 | 43 | 38 | 43 | 43 | 52 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Drive DeVilbiss Healthcare
- Medline Industries
- Invacare Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Drive DeVilbiss Healthcare | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Medline Industries | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Invacare Corporation | ◐ | ◐ | ✓ | ✓ | ✓ | ◐ |
| Arjo | ✓ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Hill-Rom Holdings (now part of Baxter International) | ✓ | ✓ | ◐ | − | ◐ | ◐ |
| Etac AB | − | ◐ | ◐ | ◐ | − | − |
| Carex Health Brands | − | − | ◐ | ◐ | − | − |
| Nova Medical Products | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Drive DeVilbiss Healthcare88
2Medline Industries86
3Invacare Corporation77
4Arjo72
5Hill-Rom Holdings (now part of Baxter International)69
6Etac AB62
7Carex Health Brands48
8Nova Medical Products46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Drive DeVilbiss HealthcareMedline Industries
Challenger3
Strong scale, closing on the leaders.
Invacare CorporationArjoHill-Rom Holdings (now part of Baxter International)
Contender1
Focused players with pockets of strength.
Etac AB
Niche2
Specialists in a single segment or region.
Carex Health BrandsNova Medical Products
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Toilet for Obese Patients Market — a $695M beachhead inside a $10.4B market.
Beachhead (SOM)$695Mobtainable near-term
Serviceable (SAM)$3.97Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Standard Bariatric Toilets
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Commode Chairs for Obese Patients
Strong fit — clear ROI and a fast path to value.
End user68 fit
Raised Height Toilets
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Installation Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel25%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Toilet for Obese Patients Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified21%
Evaluation11%
Closed-won7%
$14.1KCAC
$51KLTV
3.6:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Toilet for Obese Patients Market is a durable-growth opportunity — $5.87B by 2033, compounding at 6.6%.
TAM · 2025$3.51Btoday
TAM · 2033$5.87Bforecast
CAGR6.6%2027–2033
Cumulative$41.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.87BTotal addressable market
SAM$2.42BServiceable available market
SOM$400MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.6% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.87BLarge & growingTAM by 2033 at 6.6% CAGR
$2.42BServiceable nowreachable with today’s model
$400MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.58BBear4.3% CAGR
$5.87BBase6.6% CAGR
$7.51BBull8.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Toilet for Obese Patients Market — a $1.80B market by 2033. Plan: grow share from 8.5% to 17.5%.
Market size · 2033$1.80Btotal addressable
Market CAGR8.0%2027–2033
Target share17.5%from 8.5% today
Revenue ambition$315Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.5% | 17.5% | Behind |
| Revenue | $152M | $315M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 35.2% | 39.6% | On track |
| Customer retention | 89.9% | 93.4% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material capability
A defensible second engine — invest in Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $42M capacity & capability investment
- Greenlight bolt-on M&A in Material
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Toilet for Obese Patients Market conversation — a $2.09B market you can size, segment and defend in minutes.
Market size · 2033$2.09Btotal opportunity
Growth6.3%CAGR to 2033
Addressable buyers1,656+accounts in scope
Typical ROI7.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.2×return on cost, year one
< 2 mopayback period
$65K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Drive DeVilbiss HealthcareMedline IndustriesInvacare CorporationArjoHill-Rom Holdings (now part of Baxter International)Etac ABCarex Health BrandsNova Medical Products+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Toilet for Obese Patients Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Toilet for Obese Patients Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Toilet Chairs Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportToilet Assistance Equipment Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportToilet Aids Product Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportTOF-PET Scanner Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportTofogliflozin Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportToF Mass Spectrometer (TOFMS) Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportTofflemire Dental Matrix Retainer Market
Market size, share, segmentation and regional forecast.
$790M market · 2025 base year
View reportTofacitinib Tablets Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportTofacitinib Citrate Tablets Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportTofacitinib Citrate Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportTofacitinib Citrate API Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportToe Fixation System Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.